PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 38 filers reported holding PROFOUND MED CORP in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,928,819 | -21.6% | 679,296 | 0.0% | 5.80% | -2.0% |
| Q2 2023 | $8,837,640 | +46.7% | 679,296 | +4.8% | 5.91% | +46.2% |
| Q1 2023 | $6,024,239 | -14.7% | 648,465 | 0.0% | 4.04% | -15.1% |
| Q4 2022 | $7,061,783 | +169.5% | 648,465 | 0.0% | 4.77% | +180.8% |
| Q3 2022 | $2,620,000 | -18.5% | 648,465 | +47.0% | 1.70% | -12.8% |
| Q2 2022 | $3,215,000 | -19.0% | 441,056 | 0.0% | 1.95% | +6.5% |
| Q1 2022 | $3,970,000 | -12.1% | 441,056 | +9.7% | 1.83% | +2.0% |
| Q4 2021 | $4,516,000 | -23.3% | 402,177 | 0.0% | 1.79% | -23.2% |
| Q3 2021 | $5,888,000 | +29.8% | 402,177 | +45.1% | 2.34% | +35.5% |
| Q2 2021 | $4,536,000 | -18.8% | 277,252 | 0.0% | 1.72% | -25.0% |
| Q1 2021 | $5,584,000 | -2.0% | 277,252 | 0.0% | 2.30% | -10.3% |
| Q4 2020 | $5,700,000 | +16.5% | 277,252 | 0.0% | 2.56% | -14.7% |
| Q3 2020 | $4,891,000 | +12.4% | 277,252 | +8.0% | 3.00% | -4.1% |
| Q2 2020 | $4,350,000 | +73.9% | 256,813 | 0.0% | 3.13% | +34.1% |
| Q1 2020 | $2,501,000 | – | 256,813 | – | 2.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 341,767 | $7,029,000 | 13.80% |
| GAGNON SECURITIES LLC | 821,196 | $16,883,000 | 2.69% |
| Gagnon Advisors, LLC | 277,252 | $5,700,000 | 2.56% |
| Taylor Wealth Management Partners | 166,294 | $3,419,000 | 1.32% |
| PCJ Investment Counsel Ltd. | 126,930 | $2,611,000 | 1.22% |
| EAM Global Investors LLC | 172,291 | $3,542,000 | 0.96% |
| AWM Investment Company, Inc. | 348,939 | $7,174,000 | 0.91% |
| PURA VIDA INVESTMENTS, LLC | 780,567 | $16,048,000 | 0.58% |
| Wealth Management Partners, LLC | 20,282 | $554,000 | 0.43% |
| Parkman Healthcare Partners LLC | 69,049 | $1,420,000 | 0.36% |